Saverone 2014 Ltd. (SVRE)
Every figure this model derived for SVRE, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.
The figures, and where each came from
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 7,000 | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
2025-12-31 |
| cash | 14,279,000 | CashAndCashEquivalents |
2025-12-31 |
| current assets | 19,530,000 | CurrentAssets |
2025-12-31 |
| current liabilities | 8,363,000 | CurrentLiabilities |
2025-12-31 |
| equity | 12,243,000 | Equity |
2025-12-31 |
| interest expense | 67,000 | InterestExpense |
2025-12-31 |
| ocf | -29,207,000 | CashFlowsFromUsedInOperatingActivities |
2025-12-31 |
| revenue | 1,016,000 | Revenue |
2025-12-31 |
| sbc | 124,000 | AdjustmentsForSharebasedPayments |
2025-12-31 |
The ratios
The figures themselves rather than their scores — what somebody looking up SVRE on one particular measure came for.
| Ratio | Value |
|---|---|
| current ratio | 2.34 |
| current ratio reported | 2.34 |
| dilution pct | 3306.22 |
| growth cv | 1.63 |
| interest cover | -458.69 |
| revenue growth | -39.63 |
| revenue growth per share | -98.23 |
| rule of 40 | -3064.43 |
| sbc pct revenue | 12.2 |
Everything else this filing tags
284 more elements from SVRE's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.
| Element | Newest | As of | Periods | Unit |
|---|---|---|---|---|
NumberOfSharesAuthorised | 10,000,000,000 | 2025-06-30 | 6 | shares |
AdjustedWeightedAverageShares | 4,006,539,396 | 2025-12-31 | 24 | shares |
WeightedAverageShares | 4,006,539,396 | 2025-12-31 | 24 | shares |
WeightedAverageNumberOfInstrumentsUsedInCalculatingDilutedEarningsLossPerInstrumentParticipatingEquityInstrumentsOtherThanOrdinaryShares | 358,709,597 | 2025-06-30 | 4 | shares |
SharePremium | 200,886,000 | 2025-12-31 | 20 | ILS |
RetainedEarnings | -199,991,000 | 2025-12-31 | 20 | ILS |
DeferredTaxAssets | 177,000,000 | 2025-12-31 | 4 | ILS |
AccumulatedChangesInFairValueOfFinancialAssetsAttributableToChangesInCreditRiskOfFinancialAssets | 135,610,000 | 2023-12-31 | 4 | ILS |
AdjustmentsForFairValueGainsLosses | 108,000,000 | 2023-12-31 | 2 | ILS |
ProceedsFromExerciseOfWarrants | 37,578,000 | 2022-06-30 | 1 | ILS |
ImpairmentLossRecognisedInOtherComprehensiveIncome | 33,835,000 | 2023-12-31 | 2 | ILS |
CashFlowsFromUsedInFinancingActivities | 32,069,000 | 2025-12-31 | 24 | ILS |
ProfitLossFromOperatingActivities | -30,732,000 | 2025-12-31 | 24 | ILS |
ComprehensiveIncome | -29,443,000 | 2025-12-31 | 21 | ILS |
ProfitLoss | -29,443,000 | 2025-12-31 | 24 | ILS |
DebtSecurities | 28,844,000 | 2025-12-31 | 1 | ILS |
NumberOfSharesOutstanding | 28,321,656 | 2023-06-30 | 4 | shares |
IncreaseDecreaseInNumberOfOrdinarySharesIssued | 27,839,012 | 2023-06-30 | 7 | shares |
OtherComprehensiveIncome | -24,962,000 | 2022-12-31 | 3 | ILS |
OtherComprehensiveIncomeBeforeTax | -24,962,000 | 2022-12-31 | 3 | ILS |
Assets | 20,923,000 | 2025-12-31 | 20 | ILS |
EquityAndLiabilities | 20,923,000 | 2025-12-31 | 20 | ILS |
NetEarnedPremium | 20,887,000 | 2020-11-30 | 2 | ILS |
AcquisitiondateFairValueOfTotalConsiderationTransferred | 20,322,000 | 2025-01-01 | 2 | ILS |
IncreaseDecreaseInNumberOfSharesOutstanding | 18,997,479 | 2023-06-30 | 4 | shares |
ResearchAndDevelopmentExpense | 18,898,000 | 2025-12-31 | 24 | ILS |
OtherCashAndCashEquivalents | 17,112,000 | 2023-12-31 | 4 | ILS |
OtherFinancialLiabilities | 16,143,000 | 2023-12-31 | 2 | ILS |
FinancialAssets | 16,133,000 | 2025-12-31 | 4 | ILS |
ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity | -16,119,000 | 2025-06-30 | 12 | ILS |
ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects | -16,119,000 | 2025-06-30 | 12 | ILS |
CapitalReserve | 11,348,000 | 2025-12-31 | 20 | ILS |
PurchaseOfInterestsInAssociates | 10,028,000 | 2024-01-01 | 4 | ILS |
GrossLoanCommitments | 10,000,000 | 2023-06-05 | 1 | USD |
ContractualCapitalCommitments | 10,000,000 | 2023-06-05 | 1 | USD |
ProceedsFromIssueOfOrdinaryShares | 9,259,000 | 2023-12-31 | 1 | ILS |
RepaymentsOfBorrowingsClassifiedAsFinancingActivities | 8,860,000 | 2024-12-31 | 6 | ILS |
FinancialLiabilities | 8,680,000 | 2025-12-31 | 7 | ILS |
GeneralAndAdministrativeExpense | 8,405,000 | 2025-12-31 | 18 | ILS |
TaxEffectOfTaxLosses | -7,677,000 | 2025-12-31 | 12 | ILS |
ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities | 7,170,000 | 2023-12-31 | 8 | ILS |
OtherEquityInterest | 7,097,000 | 2023-06-30 | 1 | ILS |
AdjustmentsForAmountsTransferredToInitialCarryingAmountOfHedgedItems | 7,083,000 | 2023-06-30 | 1 | ILS |
ConsiderationPaidReceived | 7,000,000 | 2025-12-31 | 2 | ILS |
Cash | 6,893,000 | 2022-06-30 | 1 | ILS |
TaxExpenseIncomeAtApplicableTaxRate | 5,741,000 | 2022-12-31 | 3 | ILS |
AcquisitiondateFairValueOfTotalConsiderationTransferred | 5,530,000 | 2025-01-01 | 1 | USD |
IncreaseDecreaseThroughTransfersAndOtherChangesEquity | 5,487,000 | 2025-01-30 | 1 | ILS |
GrossContractualAmountsReceivableForAcquiredReceivables | 5,141,000 | 2022-12-11 | 3 | ILS |
OtherIncome | 5,099,000 | 2022-12-31 | 3 | ILS |
ProceedsFromIssuingOtherEquityInstruments | 4,900,000 | 2025-12-31 | 7 | ILS |
FinanceIncome | 4,795,000 | 2025-12-31 | 24 | ILS |
ProceedsFromBorrowingsClassifiedAsFinancingActivities | 4,650,000 | 2025-12-31 | 7 | ILS |
InventoriesTotal | 4,534,000 | 2023-12-31 | 2 | ILS |
IssuesFairValueMeasurementLiabilities | 3,947,000 | 2022-06-30 | 1 | ILS |
CurrentWarrantLiability | 3,947,000 | 2022-12-31 | 1 | ILS |
ShorttermBorrowings | 3,912,000 | 2024-06-30 | 3 | ILS |
Inventories | 3,813,000 | 2025-12-31 | 20 | ILS |
CurrentInvestments | 3,805,000 | 2023-06-30 | 7 | ILS |
ShorttermDepositsClassifiedAsCashEquivalents | 3,805,000 | 2023-06-30 | 1 | ILS |
ProceedsFromSalesOfInvestmentProperty | 3,721,000 | 2024-06-30 | 2 | ILS |
TradeAndOtherCurrentPayablesToTradeSuppliers | 3,695,000 | 2024-06-30 | 3 | ILS |
GainsOnChangeInFairValueOfDerivatives | 3,556,000 | 2025-12-31 | 6 | ILS |
FinanceCosts | 3,506,000 | 2025-12-31 | 17 | ILS |
ServicesExpense | 3,500,000 | 2023-12-31 | 5 | ILS |
CashTransferred | 3,430,000 | 2020-02-23 | 1 | ILS |
FinanceIncomeReceivedClassifiedAsOperatingActivities | -3,408,000 | 2022-12-31 | 3 | ILS |
SalesAndMarketingExpense | 3,355,000 | 2025-12-31 | 24 | ILS |
SellingExpense | 3,355,000 | 2025-12-31 | 9 | ILS |
ProfessionalFeesExpense | 3,341,000 | 2025-12-31 | 9 | ILS |
SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares | 2,941,918 | 2022-06-06 | 3 | shares |
TradeAndOtherCurrentPayables | 2,896,000 | 2023-06-30 | 8 | ILS |
IncreaseDecreaseInCashAndCashEquivalents | 2,855,000 | 2025-12-31 | 24 | ILS |
PurchaseOfInterestsInAssociates | 2,744,000 | 2024-01-01 | 4 | USD |
OtherCurrentLiabilities | 2,742,000 | 2025-12-31 | 14 | ILS |
FinancialLiabilitiesAtFairValue | 2,735,000 | 2024-12-31 | 3 | ILS |
OtherBorrowings | 2,735,000 | 2024-12-31 | 1 | ILS |
RawMaterials | 2,464,000 | 2025-12-31 | 8 | ILS |
CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale | 2,456,000 | 2023-06-30 | 6 | ILS |
OtherCashReceiptsFromOperatingActivities | 2,402,000 | 2019-12-31 | 1 | ILS |
RepaymentsOfBorrowingsClassifiedAsFinancingActivities | 2,250,000 | 2024-12-31 | 1 | USD |
FeeAndCommissionExpense | 2,112,000 | 2025-12-31 | 3 | ILS |
EffectOfExchangeRateChangesOnCashAndCashEquivalents | -2,009,000 | 2025-12-31 | 19 | ILS |
TradeAndOtherCurrentReceivables | 1,860,000 | 2023-06-30 | 8 | ILS |
ShorttermEmployeeBenefitsAccruals | 1,768,000 | 2025-12-31 | 4 | ILS |
IssueOfEquity | 1,657,000 | 2025-12-31 | 13 | ILS |
TradeAndOtherReceivables | 1,638,000 | 2025-12-31 | 4 | ILS |
PostemploymentBenefitExpenseDefinedContributionPlans | 1,597,000 | 2025-12-31 | 12 | ILS |
OtherSellingGeneralAndAdministrativeExpense | 1,591,000 | 2022-12-31 | 3 | ILS |
EmployeeBenefitsExpense | 1,574,000 | 2023-12-31 | 4 | ILS |
UndiscountedFinanceLeasePaymentsToBeReceived | 1,525,000 | 2023-12-31 | 1 | USD |
IncreaseDecreaseThroughTransfersAndOtherChangesEquity | 1,520,000 | 2025-01-30 | 1 | USD |
NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement | 1,510,853 | 2025-12-31 | 8 | pure |
CurrentPrepaymentsAndOtherCurrentAssets | 1,509,000 | 2023-12-31 | 10 | ILS |
GrossContractualAmountsReceivableForAcquiredReceivables | 1,500,000 | 2022-12-11 | 2 | USD |
LiabilitiesFromSharebasedPaymentTransactions2011 | 1,456,000 | 2021-12-31 | 1 | ILS |
NoncurrentAssets | 1,393,000 | 2025-12-31 | 20 | ILS |
FinishedGoods | 1,349,000 | 2025-12-31 | 8 | ILS |
NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement | 1,315,970 | 2025-12-31 | 6 | pure |
FinanceIncomeCost | 1,289,000 | 2025-12-31 | 15 | ILS |
AdjustmentsForIncreaseDecreaseInTradeAccountPayable | -1,220,000 | 2025-12-31 | 18 | ILS |
AdjustmentsForDecreaseIncreaseInInventories | 1,200,000 | 2025-12-31 | 21 | ILS |
TradeReceivables | 1,186,000 | 2025-12-31 | 14 | ILS |
OtherCurrentReceivables | 1,186,000 | 2025-12-31 | 4 | ILS |
ProceedsFromIssuingShares | 1,130,000 | 2024-06-25 | 2 | USD |
AdditionsToRightofuseAssets | 1,129,000 | 2023-12-31 | 2 | ILS |
LossesArisingFromDerecognitionOfFinancialAssetsMeasuredAtAmortisedCost | 1,129,000 | 2023-12-31 | 5 | ILS |
WagesAndSalaries | 1,086,000 | 2025-12-31 | 6 | ILS |
ProceedsFromIssuingShares | 1,076,000 | 2025-12-31 | 11 | ILS |
CostsAndExpensesRelatedParty | 1,062,000 | 2022-12-31 | 2 | ILS |
MiscellaneousOtherOperatingExpense | 1,056,000 | 2025-12-31 | 9 | ILS |
AdditionsFromAcquisitionsInvestmentProperty | 1,029,000 | 2025-12-31 | 3 | ILS |
AdditionsToOtherAssetsAmount | 1,029,000 | 2022-12-31 | 1 | ILS |
CashTransferred | 1,000,000 | 2020-02-23 | 1 | USD |
AccrualsClassifiedAsCurrent | 974,000 | 2025-12-31 | 6 | ILS |
OtherNoncurrentNonfinancialLiabilities | 970,000 | 2023-06-30 | 8 | ILS |
TaxEffectFromChangeInTaxRate | 953,000 | 2025-12-31 | 6 | ILS |
OtherNoncurrentLiabilities | 919,000 | 2022-12-31 | 2 | ILS |
IncreaseDecreaseInCreditDerivativeFairValue | -877,000 | 2023-12-31 | 3 | ILS |
ReserveOfExchangeDifferencesOnTranslation | 852,000 | 2022-12-31 | 3 | ILS |
AdjustmentsForDecreaseIncreaseInTradeAccountReceivable | 787,000 | 2025-12-31 | 21 | ILS |
PaymentsOfOtherEquityInstruments | 750,000 | 2021-12-31 | 3 | ILS |
OtherBorrowings | 750,000 | 2024-12-31 | 1 | USD |
OtherAdjustmentsToReconcileProfitLoss | 741,000 | 2025-12-31 | 9 | ILS |
UndiscountedFinanceLeasePaymentsToBeReceived | 740,000 | 2025-12-31 | 3 | ILS |
IncomeFromGovernmentGrantsRelatedToAgriculturalActivity | 735,000 | 2025-12-31 | 3 | ILS |
TradeAndOtherCurrentReceivablesDueFromRelatedParties | 724,000 | 2025-12-31 | 4 | ILS |
AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | 723,000 | 2022-12-31 | 4 | ILS |
InterestExpenseOnBorrowings | 722,000 | 2025-12-31 | 5 | ILS |
CostOfSales | 713,000 | 2025-12-31 | 24 | ILS |
OtherGainsLosses | -678,000 | 2022-12-31 | 3 | ILS |
LeaseLiabilities | 673,000 | 2025-12-31 | 10 | ILS |
PropertyPlantAndEquipmentGrossCarryingAmountFullyDepreciated | 656,000 | 2025-12-31 | 12 | ILS |
InvestmentIncome | 630,000 | 2020-05-24 | 1 | ILS |
SellingGeneralAndAdministrativeExpense | 624,000 | 2023-12-31 | 12 | ILS |
FairValueOfAcquiredReceivables | 622,000 | 2024-12-31 | 2 | ILS |
TradeAndOtherPayables | 606,000 | 2025-12-31 | 6 | ILS |
TradeAndOtherPayablesToTradeSuppliers | 606,000 | 2025-12-31 | 9 | ILS |
AmountsPayableToTransfereeInRespectOfTransferredAssets | 600,000 | 2022-12-31 | 1 | ILS |
TransfersOfCumulativeGainLossWithinEquity | 600,000 | 2020-12-31 | 1 | ILS |
AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables | -596,000 | 2022-12-31 | 3 | ILS |
RightofuseAssets | 571,000 | 2025-12-31 | 20 | ILS |
RentalIncome | 533,000 | 2025-12-31 | 4 | ILS |
OtherIncome | 529,000 | 2022-12-31 | 3 | ILS |
ShareIssueRelatedCost | 504,000 | 2025-12-31 | 4 | ILS |
AdjustmentsForInterestExpense | 494,000 | 2024-06-30 | 5 | ILS |
CurrentLeaseLiabilities | 469,000 | 2025-12-31 | 20 | ILS |
PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | 469,000 | 2025-12-31 | 24 | ILS |
ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities | 469,000 | 2025-12-31 | 6 | ILS |
CurrentTradeReceivables | 462,000 | 2025-12-31 | 6 | ILS |
IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions | 458,000 | 2023-12-31 | 3 | ILS |
InsuranceExpense | 456,000 | 2025-12-31 | 12 | ILS |
NoncurrentReceivables | 452,000 | 2025-12-31 | 11 | ILS |
NoncurrentTradeReceivables | 452,000 | 2025-12-31 | 4 | ILS |
OtherNoncurrentReceivables | 452,000 | 2025-12-31 | 4 | ILS |
InterestIncomeOnDeposits | 426,000 | 2025-12-31 | 6 | ILS |
AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill | 425,000 | 2022-12-31 | 3 | ILS |
RightofuseAssetFairValueUsedAsDeemedCost | 425,000 | 2023-12-31 | 3 | USD |
InterestReceivedClassifiedAsOperatingActivities | 404,000 | 2024-12-31 | 6 | ILS |
OtherCurrentNonfinancialLiabilities | 401,000 | 2023-06-30 | 8 | ILS |
OtherCurrentAssets | 387,000 | 2025-12-31 | 12 | ILS |
CurrentAccruedExpensesAndOtherCurrentLiabilities | 381,000 | 2025-12-31 | 4 | ILS |
RightofuseAssetFairValueUsedAsDeemedCost | 380,000 | 2025-12-31 | 9 | ILS |
AdjustmentsForAmortisationExpense | 380,000 | 2025-12-31 | 18 | ILS |
ImpairmentLoss | 377,000 | 2025-12-31 | 1 | ILS |
ReversalOfInventoryWritedown | 377,000 | 2025-12-31 | 1 | ILS |
MiscellaneousOtherOperatingIncome | 339,000 | 2023-12-31 | 3 | ILS |
NoncurrentAdvances | 335,000 | 2022-12-31 | 2 | ILS |
DirectorsRemunerationExpense | 320,000 | 2025-12-31 | 12 | ILS |
NoncurrentLiabilities | 317,000 | 2025-12-31 | 20 | ILS |
RevenueFromGovernmentGrants | 299,000 | 2023-12-31 | 6 | ILS |
AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities | -274,000 | 2024-12-31 | 9 | ILS |
DerivativeFinancialLiabilities | 274,000 | 2023-12-31 | 1 | ILS |
AdjustmentsForDecreaseIncreaseInOtherAssets | 262,000 | 2024-06-30 | 12 | ILS |
NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement | 253,001 | 2025-12-31 | 5 | pure |
AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities | -249,000 | 2025-12-31 | 21 | ILS |
ProfitLossBeforeTax | 244,000 | 2021-12-31 | 2 | ILS |
IntangibleAssetsAcquiredByWayOfGovernmentGrant | 240,000 | 2023-12-31 | 5 | ILS |
AdjustmentsForReconcileProfitLoss | 236,000 | 2025-12-31 | 15 | ILS |
TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss | 225,000 | 2023-12-31 | 6 | ILS |
AdjustmentsForDecreaseIncreaseInOtherCurrentAssets | 223,000 | 2025-12-31 | 9 | ILS |
LongtermDeposits | 216,000 | 2025-12-31 | 6 | ILS |
AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables | -214,000 | 2023-06-30 | 9 | ILS |
NoncurrentLeaseLiabilities | 204,000 | 2025-12-31 | 18 | ILS |
NumberOfInstrumentsOtherEquityInstrumentsGranted | 194,500 | 2024-12-31 | 5 | pure |
ExpenseFromSharebasedPaymentTransactionsWithEmployees | 191,000 | 2025-01-30 | 4 | ILS |
ProceedsFromExerciseOfOptions | 188,000 | 2023-06-30 | 2 | ILS |
InvestmentIncome | 180,000 | 2020-05-24 | 1 | USD |
GovernmentGrants | 175,000 | 2025-12-31 | 18 | ILS |
IncreaseDecreaseThroughSharebasedPaymentTransactions | 175,000 | 2025-12-31 | 23 | ILS |
FairValueOfAcquiredReceivables | 171,000 | 2024-12-31 | 2 | USD |
ShareIssueRelatedCost | 163,000 | 2025-01-30 | 2 | USD |
CurrentPrepaidExpenses | 161,000 | 2025-12-31 | 8 | ILS |
IncreaseDecreaseThroughOtherContributionsByOwners | 158,000 | 2022-12-31 | 4 | ILS |
IncreaseDecreaseThroughExerciseOfWarrantsEquity | 158,000 | 2022-12-31 | 2 | ILS |
PropertyPlantAndEquipment | 154,000 | 2025-12-31 | 20 | ILS |
TradeAndOtherPayablesToRelatedParties | 140,000 | 2023-12-31 | 1 | ILS |
OtherCurrentFinancialAssets | 135,000 | 2025-12-31 | 5 | ILS |
FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss | -115,000 | 2023-06-30 | 9 | ILS |
AmountsPayableRelatedPartyTransactions | 113,000 | 2022-12-31 | 2 | ILS |
NoncurrentGovernmentGrants | 113,000 | 2025-12-31 | 12 | ILS |
DebtInstrumentsHeld | 111,000 | 2025-12-31 | 2 | ILS |
BorrowingCostsIncurred | 111,000 | 2023-12-11 | 1 | ILS |
NumberOfShareOptionsExercisableInSharebasedPaymentArrangement | 107,000 | 2024-06-30 | 5 | pure |
NoncurrentReceivablesDueFromRelatedParties | 106,000 | 2024-12-31 | 2 | ILS |
WeightedAverageFairValueAtMeasurementDateShareOptionsGranted | 106,000 | 2024-12-31 | 7 | ILS |
ContingentConsiderationRecognisedAsOfAcquisitionDate | 96,000 | 2020-12-31 | 1 | ILS |
OtherAssets | 91,000 | 2025-12-31 | 5 | ILS |
ProvisionUsedOtherProvisions | 89,000 | 2025-12-31 | 2 | ILS |
IncreaseDecreaseThroughTransactionsWithOwners | 87,000 | 2023-12-31 | 2 | ILS |
AdjustmentsForDepreciationExpense | 82,000 | 2025-12-31 | 21 | ILS |
CurrentAdvancesToSuppliers | 79,000 | 2022-12-31 | 2 | ILS |
ForeignExchangeGain | 78,000 | 2025-12-31 | 6 | ILS |
GrossProfit | -74,000 | 2025-12-31 | 24 | ILS |
AdjustmentsForCurrentTaxOfPriorPeriod | 74,000 | 2023-12-31 | 3 | ILS |
RentalExpense | 70,000 | 2024-01-01 | 5 | ILS |
NumberOfSharesIssuedButNotFullyPaid | 68,152 | 2023-06-05 | 2 | shares |
InterestExpenseOnLeaseLiabilities | 67,000 | 2025-12-31 | 9 | ILS |
ProceedsFromSalesOfInterestsInAssociates | 67,000 | 2025-12-31 | 21 | ILS |
DiscountedUnguaranteedResidualValueOfAssetsSubjectToFinanceLease | 67,000 | 2025-12-31 | 2 | ILS |
CurrentGovernmentGrants | 62,000 | 2025-12-31 | 12 | ILS |
CurrentDerivativeFinancialLiabilities | 54,000 | 2025-06-30 | 16 | ILS |
OtherCurrentFinancialLiabilities | 50,000 | 2022-12-31 | 2 | ILS |
AdditionalRecognitionGoodwill | 42,000 | 2023-06-30 | 1 | ILS |
AdministrativeExpense | 42,000 | 2025-12-31 | 9 | ILS |
CurrentRestrictedCashAndCashEquivalents | 40,000 | 2021-06-30 | 1 | ILS |
DebtInstrumentsHeld | 30,000 | 2025-12-31 | 3 | USD |
InterestPaidClassifiedAsOperatingActivities | 28,000 | 2020-12-31 | 1 | ILS |
ForeignExchangeLoss | 28,000 | 2023-06-30 | 1 | ILS |
InterestExpenseOther | 28,000 | 2020-12-31 | 1 | ILS |
InterestExpenseOnLeaseLiabilities | 22,000 | 2023-12-31 | 3 | USD |
AccumulatedOtherComprehensiveIncome | 11,900 | 2022-06-30 | 1 | ILS |
ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax | 10,000 | 2023-12-31 | 6 | ILS |
RoyaltyExpense | 10,000 | 2021-12-31 | 2 | ILS |
CashFlowsFromUsedInInvestingActivities | -7,000 | 2025-12-31 | 24 | ILS |
AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | 7,000 | 2025-12-31 | 8 | ILS |
CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments | -5,000 | 2024-12-31 | 18 | ILS |
PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents | 4,900 | 2025-01-30 | 1 | ILS |
NumberOfSharesIssued | 1,200 | 2025-02-28 | 23 | shares |
WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 | 1,120 | 2020-12-31 | 1 | ILS/shares |
IntangibleAssetsAcquiredByWayOfGovernmentGrant | 876 | 2022-12-31 | 2 | USD |
CreditDerivativeFairValue | 504 | 2025-01-30 | 1 | ILS |
AmountsPayableRelatedPartyTransactions | 113 | 2022-12-31 | 1 | USD |
ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets | 55 | 2025-12-31 | 1 | ILS |
GainsLossesOnChangeInFairValueOfDerivatives | 54 | 2025-06-30 | 1 | ILS |
WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 | 7 | 2025-12-31 | 12 | ILS/shares |
WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 | 6 | 2025-12-31 | 16 | ILS/shares |
DividendsPaidOrdinarySharesPerShare | 5 | 2022-06-30 | 2 | USD/shares |
ParValuePerShare | 4 | 2022-06-30 | 2 | USD/shares |
AdjustmentToProfitLossForPreferenceShareDividends | 4 | 2022-06-30 | 2 | USD |
DividendsPaidOtherSharesPerShare | 4 | 2022-06-06 | 1 | USD/shares |
WeightedAverageSharePrice2019 | 4 | 2023-12-31 | 2 | USD/shares |
AverageForeignExchangeRate | 4 | 2023-12-31 | 1 | pure |
WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 | 2 | 2025-12-31 | 9 | ILS/shares |
WeightedAverageSharePriceShareOptionsGranted2019 | 1 | 2022-12-31 | 2 | ILS/shares |
DescriptionOfExpectedVolatilityShareOptionsGranted | 1 | 2024-12-31 | 6 | pure |
ExercisePriceOfOutstandingShareOptions2019 | 1 | 2023-12-31 | 5 | ILS/shares |
NumberOfSharesIssuedAndFullyPaid | 1 | 2022-12-31 | 3 | shares |
ExercisePriceShareOptionsGranted2019 | 1 | 2024-06-30 | 3 | ILS/shares |
FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished | 1 | 2023-12-31 | 1 | USD |
BasicEarningsLossPerShare | -1 | 2023-06-30 | 3 | USD/shares |
DilutedEarningsLossPerShare | -1 | 2023-06-30 | 3 | USD/shares |
BasicEarningsLossPerShareFromDiscontinuedOperations | 1 | 2023-12-13 | 6 | USD/shares |
TaxRateEffectOfRevenuesExemptFromTaxation | 0 | 2025-12-31 | 3 | pure |
WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 | 0 | 2024-12-31 | 11 | ILS/shares |
ExpectedDividendAsPercentageShareOptionsGranted | 0 | 2022-12-31 | 3 | pure |
PercentageOfEntitysRevenue | 0 | 2024-12-31 | 6 | pure |
DepreciationRatePropertyPlantAndEquipment | 0 | 2023-12-31 | 2 | pure |
BorrowingsInterestRate | 0 | 2025-10-30 | 8 | pure |
DepreciationRateInvestmentPropertyCostModel | 0 | 2023-12-31 | 1 | pure |
BorrowingsAdjustmentToInterestRateBasis | 0 | 2025-12-31 | 4 | pure |
TaxRateEffectFromChangeInTaxRate | 0 | 2023-12-31 | 6 | pure |
WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 | 0 | 2025-12-31 | 4 | pure |
LesseeFinanceLeaseDiscountRate | 0 | 2022-12-31 | 1 | pure |
PercentageOfVotingEquityInterestsAcquired | 0 | 2025-12-31 | 6 | pure |
DescriptionOfRiskFreeInterestRateShareOptionsGranted | 0 | 2024-12-31 | 11 | pure |
DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse | 0 | 2025-12-31 | 5 | pure |
TaxRateEffectOfTaxLosses | 0 | 2023-12-31 | 3 | pure |
BasicEarningsLossPerShare | -0 | 2025-12-31 | 21 | ILS/shares |
DilutedEarningsLossPerShare | -0 | 2025-12-31 | 21 | ILS/shares |
DividendsPaidOrdinarySharesPerShare | 0 | 2023-06-30 | 4 | ILS/shares |
ParValuePerShare | 0 | 2025-06-30 | 7 | ILS/shares |
WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019 | 0 | 2023-06-30 | 1 | ILS/shares |
CreditDerivativeFairValue | 0 | 2023-12-31 | 1 | USD |
What to be careful about
What this model itself distrusts about SVRE's figures. Written by the derivation as it ran, not added afterwards.
- WITHHELD: operating margin, cash operating margin, owner earnings margin, fcf margin, net margin, ocf margin, ebitda margin -- operating margin came out at -3,025% against a scale that tops out near 2,500%, which is arithmetic on a revenue figure of 1,016,000 rather than a margin. The figure is absent rather than corrected: there is no right value to put here.
- revenue is annual, not TTM
- operating income is annual, not TTM
- reports in ILS while its share price is quoted in USD, and no exchange rate could be used (no rate for USD to ILS that is less than 30 days old, and this is not a refresh). Every multiple would pair one currency with another, so none of them is a ratio — set `market_cap` in overrides.yaml in ILS to score it
- analyst estimate not used: trailing EPS is not positive, so a growth rate would be meaningless
- quality DROPPED from the total: only 1 of 5 inputs could be computed (operating margin, roic, owner earnings, cash operating margin not tagged), so the score is not meaningful. Its weight is spread over the other dimensions
- valuation DROPPED from the total: only 0 of 2 inputs could be computed (ev sales, ev owner earnings not tagged), so the score is not meaningful. Its weight is spread over the other dimensions
- durability rests on 3 of 4 inputs; not tagged: contracted coverage
- 2 of 5 dimensions could not be measured (quality, valuation -- 55% of the model), so this row is not comparable with the others; its total rests on what was left